« Back to Record
Citation APA

Bertrums, E. E., Zwaan, C. M., Hasegawa, D., de Haas, V., Reinhardt, D. D., Locatelli, F., De Moerloose, B. M. J. B., Dworzak, M., Buijs, A., Smisek, P., Kolenova, A., Pronk, C. J., Klusmann, J. H., Carboné, A., Ferster, A., Antoniou, E., Meshinchi, S., Raimondi, S. C., Niemeyer, C. M., Hasle, H., van den Heuvel-Eibrink, M. M., & Goemans, B. F. (2022). Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS. Haematologica, 107(3), 759-4764. doi:10.3324/haematol.2021.279507


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/378989

Bertrums, E. E., Zwaan, C. M., Hasegawa, D., de Haas, V., Reinhardt, D. D., Locatelli, F., De Moerloose, B. M. J. B., Dworzak, M., Buijs, A., Smisek, P., Kolenova, A., Pronk, C. J., Klusmann, J. H., Carboné, A., Ferster, A., Antoniou, E., Meshinchi, S., Raimondi, S. C., Niemeyer, C. M., Hasle, H., van den Heuvel-Eibrink, M. M., & Goemans, B. F. (2022). Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS. Haematologica, 107(3), 759-4764. doi:10.3324/haematol.2021.279507